Abstract
Purpose
To investigate gender differences in clinicopathological features and to analyze the prognostic impact of gender in renal cell carcinoma (RCC) patients undergoing surgery.
Methods
A total of 6,234 patients (eleven centers; Europe and USA) treated by radical or partial nephrectomy were included in this retrospective study (median follow-up 59 months; IQR 30–106). Gender differences in clinicopathological parameters were assessed. Multivariable Cox regression models were applied to determine the influence of parameters on disease-specific survival (DSS) and overall survival (OS).
Results
A total of 3,751 patients of the study group were male patients (60.2 %), who were significantly younger at diagnosis and received more frequently NSS than women. Significantly, more often high-grade tumors and simultaneous metastasis were present in men. Whereas tumor size and pTN stages did not differ between genders, clear-cell and chromophobe RCC was diagnosed less frequently, but papillary RCC more often in men. Gender also independently influenced DSS (HR 0.75, p < 0.001) and OS (HR 0.80, p < 0.001) with a benefit for women. However, inclusion of gender in multivariable models did not significantly gain predictive accuracies (PA) for DSS (0.868–0.870, p = 0.628) and OS (0.775–0.777, p = 0.522). Furthermore, no significantly different DSS and OS rates were found in patients undergoing NSS.
Conclusions
This study demonstrates important gender differences in clinicopathological features and outcome of RCC patients with improved DSS and OS for women compared to men, even if solely patients with clear-cell RCC or M0-stage are taken into evaluation. However, inclusion of gender in multivariable models does not significantly gain PA of multivariable models.
Similar content being viewed by others
References
Pierorazio PM, Murphy AM, Benson MC, McKiernan JM (2007) Gender discrepancies in the diagnosis of renal cortical tumors. World J Urol 25(1):81–85
Aron M, Nguyen MM, Stein RJ, Gill IS (2008) Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol 54(1):133–140
Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR (2008) Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol 179(5):1704–1708
Woldrich JM, Mallin K, Ritchey J, Carroll PR, Kane CJ (2008) Sex differences in renal cell cancer presentation and survival: an analysis of the National Cancer Database, 1993–2004. J Urol 179(5):1709–1713
Schrader AJ, Sevinc S, Olbert PJ, Hegele A, Varga Z, Hofmann R (2008) Gender-specific characteristics and survival of renal cell carcinoma. Urologe 47(9):1182, 1184–6
Chen J, Shi B, Zhang D, Jiang X, Xu Z (2009) The clinical characteristics of renal cell carcinoma in female patients. Int J Urol 16(6):554–557
Lee S, Jeon HG, Kwak C, Kim HH, Byun SS, Lee SE, Lee E (2012) Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC). BJU Int 110:28–33
Hew MN, Zonneveld R, Kümmerlin IP, Opondo D, de la Rosette JJ, Laguna MP (2012) Age and gender related differences in renal cell carcinoma in a European cohort. J Urol 188(1):33–38
Greene FL, Gospodarowicz M, Wittekend C et al (2009) American Joint Committee on Cancer (AJCC) staging manual, 7th edn. Springer, Philadelphia
Fuhrman S, Lasky LC, Limas L (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663
Kovacs G, Akhtar M, Beckwith BJ et al (1997) The Heidelberg classification of renal cell tumours. J Pathol 183(2):131–133
Brookman-May S, May M, Ficarra V et al (2012) Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series. World J Urol. doi:10.1007/s00345-012-0931-0
Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387
Murai M (2008) Editorial comment on: impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol 54(1):140–141
Sun M, Shariat SF, Cheng C et al (2011) Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol 60(4):644–661
Langner C, Ratschek M, Rehak P et al (2004) Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors. J Urol 171(2 Pt 1):611–614
Eichelberg C, Minner S, Isbarn H et al (2011) Prognostic value of alpha-methyl CoA racemase (AMACR) expression in renal cell carcinoma. World J Urol. doi:10.1007/s00345-011-0783-z
Costa WH, Rocha RM, Cunha IW, Fonseca FP, Guimaraes GC, Zequi Sde C (2012) CD133 immunohistochemical expression predicts progression and cancer-related death in renal cell carcinoma. World J Urol 30(4):553–558
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Matthias May and Atiqullah Aziz have equally contributed to first authorship.
Rights and permissions
About this article
Cite this article
May, M., Aziz, A., Zigeuner, R. et al. Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database. World J Urol 31, 1073–1080 (2013). https://doi.org/10.1007/s00345-013-1071-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-013-1071-x